A single center,open-lable,self-controlled clinical study of MEBO in the treatment of recessive dystrophic epidermolysis bullosa
    BEB6678
     Ms. Yang Yu
Shantou MEBO Pharmaceutical Co., Ltd, China
Shantou MEBO Pharmaceutical Co., Ltd, China
Currently, there is no question has been asked, you are welcome to ask a question.
Return